DM
ARRY

Deerfield Management’s Array Biopharma Inc ARRY Stock Holding History

Deerfield Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,142,744
Closed -$10.2M – 106
2017
Q1 		$10.2M Sell
1,142,744
-507,256
-31% -$5.4M 0.39% 65
2016
Q4 		$14.5M Hold
1,650,000
– – 0.6% 51
2016
Q3 		$11.1M Sell
1,650,000
-6,711,069
-80% -$26M 0.52% 45
2016
Q2 		$29.8M Sell
8,361,069
-1,168,292
-12% -$3.81M 1.17% 32
2016
Q1 		$28.1M Buy
9,529,361
+800,000
+9% +$2.4M 1.2% 30
2015
Q4 		$36.8M Sell
8,729,361
-1,000,000
-10% -$4.56M 1.49% 17
2015
Q3 		$44.4M Buy
9,729,361
+200,000
+2% +$1.19M 1.72% 13
2015
Q2 		$68.7M Sell
9,529,361
-2,305,234
-19% -$17M 2.29% 5
2015
Q1 		$87.2M Hold
11,834,595
– – 2.83% 6
2014
Q4 		$56M Sell
11,834,595
-371,078
-3% -$1.47M 2.01% 15
2014
Q3 		$43.6M Hold
12,205,673
– – 1.59% 23
2014
Q2 		$55.7M Hold
12,205,673
– – 2.24% 9
2014
Q1 		$57.4M Buy
12,205,673
+970,267
+9% +$4.88M 2.34% 10
2013
Q4 		$56.3M Buy
11,235,406
+650,000
+6% +$3.54M 2.92% 6
2013
Q3 		$65.8M Sell
10,585,406
-300,000
-3% -$1.78M 3.06% 4
2013
Q2 		$49.4M Buy
+10,885,406
New +$58.5M 2.33% 8

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management's ARRY Position: Q2 2017 in Review

Deerfield Management sold out of Array Biopharma Inc (ARRY) in Q2 2017, closing a stake of 1,142,744 shares — an estimated $10.2M sold.

Deerfield Management first reported a position in ARRY in Q2 2013 and held it in 16 quarters. The position peaked at $87.2M in Q1 2015. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Deerfield Management reported no remaining Array Biopharma Inc position as of Q2 2017 after selling out during the quarter.
  • Deerfield Management sold 1,142,744 Array Biopharma Inc shares in Q2 2017, an estimated $10.2M.
  • Deerfield Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 16 quarters.
  • Deerfield Management's Array Biopharma Inc position peaked at $87.2M in Q1 2015.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.